About the Journal | Editorial Board | Instructions to Contributors | Submission & Review | Advertise with Us | Subscribe to E- Alerts
Sitemap | Feedback
Advanced search
Journal of Case Reports
Double Primary Cancers Registered in Tertiary Care Hospital: Review of Cases

buy ru486 abortion pill online

can i buy the abortion pill over the counter
Amrallah A. Mohammad1,2, Abdullah S. Al-Zahrani1, Hani M.EL-Khatib1
From the Oncology Center, King Abdullah Medical City-Holy Capital, Saudi Arabia1; Department of Medical Oncology, Faculty of Medicine, Zagazig University, Egypt2.
Corresponding Author:
Dr. Amrallah A. Mohammad
Email: amrallaabdelmoneem@yahoo.com
Received: 29-DEC-2013 Accepted: 06-FEB-2014 Published Online: 20-FEB-2014
DOI: http://dx.doi.org/10.17659/01.2014.0018
Abstract
In our center, among 1965 patients registered with malignancies for treatment during the period from May 2011 till December 2013, 3 cases with multiple primary tumors (MPMs) reported, one of them was excluded due to inadequacy of data and we present the remaining two cases. First case was 82 years old female patient with colon cancer and thyroid malignancy, the second case was 61 years old female patient with colon cancer and breast cancer. Both cases were metachronous and discovered accidently during the regular follow up, and managed in curative intent. These cases are being reported to make clinicians aware that individuals with cancer are at increased risk for subsequent cancers, which must be differentiated from recurrent or metastatic disease as the treatment plan will be different. 
Keywords : Multiple Primary, Colonic Neoplasms, Breast Neoplasms, Thyroid Neoplasms.
Article Options
FULL TEXT
ABSTRACT
PDF
PRINTER FRIENDLY VERSION
Search PubMed for
Search Google Scholar for
Article Statistics
Bookmark and Share

Androxal Medication Case Reports Journal

Expanding our scope, the Journal now encompasses an intriguing subset of articles specifically targeting treatments and patient outcomes related to the medication Androxal. This medication, primarily used in the treatment of male infertility, has shown unique potentials in diverse patient scenarios. Our studies with Androxal have given us an abundance of case reports, which demonstrate the multifaceted impact of this medication across therapeutic areas. This nuanced pharmaceutical perspective adds a fresh dimension to our regular case reports. Articles will reveal effective management processes, pinpointing how Androxal has proven beneficial where other treatments may have failed. In addition, the focus on Androxal will highlight instances of challenging or unexpected outcomes, where the medication may have interacted uniquely with the patient's unique biological system or interplayed with other treatments. As we forge ahead with this significant addition, we anticipate that our detailed case reports on Androxal will provide invaluable insights to both practitioners and patients navigating their medical journey with this medication.

© 2011 Journal of Case Reports
Last updated on Jan 19, 2025